Biohaven (BHVN) Stock: Buy, Sell, or Hold?
BHVN - Biohaven Ltd.
$13.99
-0.70 (-4.77%)
▼
5d:
+29.78%
30d:
+6.07%
90d:
-3.58%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 09, 2026
16d
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Oct 16, 2026 at $10.89 · last confirmed Oct 19, 2026
Strength: 7.8/10
Get Alerted When BHVN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: BHVN shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: BHVN shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: BHVN is currently trading at $13.99, which is considered extended relative to its 30-day fair value range of $11.60 to $13.75.
Technical Outlook: Technically, BHVN is in a downtrend. Immediate support is located at $10.70, while resistance sits at $16.54. Short-term momentum is weak, with the stock down 4.8% recently.
Market Sentiment: BHVN scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $21.27 (+44.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BHVN is in a downtrend. Immediate support is located at $10.70, while resistance sits at $16.54. Short-term momentum is weak, with the stock down 4.8% recently.
Market Sentiment: BHVN scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $21.27 (+44.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$11.60 -
$13.75
Company Quality Score
40/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
21.1%
Protect Your Profits
Holding BHVN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.8%)
- BULLISH: Trading 44.8% below Wall St target ($21.27)
- WARNING: Composite score 40/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$11.60 -
$13.75
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$10.70
Resistance Level
$16.54
Current Trend
Downtrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.85
Wall Street Target
$21.27
(+44.8%)
Share & Embed Analysis
Last updated: October 23, 2026 2:44 PM ET
Data refreshes hourly during market hours. Next update: 3:44 PM
Data refreshes hourly during market hours. Next update: 3:44 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BHVN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
28 analysts |
$92 | 73 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
23 analysts |
$108 | 58 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$130 | 69 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$283 | 43 HOLD |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
20 analysts |
$17 | 47 HOLD |
Advanced BHVN Option Strategies
Professional options setups generated by AI based on today's BHVN price and gamma walls.
